Lab-on-a-Chip: Revolutionizing Lactic Acid Production
"How microfluidics is making it easier to screen engineered strains of yeast for lactic acid production"
Biotechnology is constantly evolving, with researchers always seeking more efficient and effective ways to develop bioprocesses. One major area of focus is optimizing the production of valuable compounds like lactic acid, which has applications ranging from food to biodegradable plastics.
Traditional methods for optimizing bioproduction can be time-consuming and require significant resources. This is where microfluidics comes in. Microfluidic devices, often called "lab-on-a-chip" systems, offer a way to miniaturize and automate biological experiments.
This article explores how researchers are using microfluidic technology to streamline the screening of engineered yeast strains for improved lactic acid production. By scaling down experiments and integrating sensors, scientists can gain a better understanding of cell behavior and optimize bioprocesses more rapidly.
Droplet Screening and Lactic Acid Applications
A 2019 mini-review describes a droplet-microfluidic screening system for high lactic acid-producing Bacillus coagulans, using water-in-oil-in-water droplets of about 12 pL as fermentation picoliter-reactors. A 2026 study reports a related high-throughput approach that combines single-cell cultivation, adaptation, and fluorescence-activated droplet sorting to isolate lactic acid bacteria capable of in situ riboflavin production in soy-based substrates. Separately, a 2014 study examined glass-capillary microfluidics for producing monodispersed poly(dl-lactic acid) and polycaprolactone microparticles; this concerns materials production rather than lactic acid fermentation.
Fermentation Costs and Screening Challenges
A 2016 review identifies substrate and lactic acid concentration, yield, and productivity as key parameters that determine the final cost of lactic acid production. It focuses on limitations and challenges in cost-efficient microbial production of optically pure lactic acid. A 2023 review notes that fermentation using renewable resources such as lignocellulosic materials can offer a cheaper alternative and reduce greenhouse gas emissions, while demand for lactic acid is rising with demand for polylactic acid. A 2019 mini-review presents droplet-based microfluidics as a potential tool for screening lactic acid bacteria during strain improvement.
Microfluidics and Lactic Acid Research
The supplied article describes microfluidic devices, often called lab-on-a-chip systems, as a way to miniaturize and automate biological experiments. It frames their application to lactic acid production around streamlining the screening of engineered yeast strains. A 2023 concise review says microfluidics can rapidly process samples and precisely manipulate fluids in assays, presenting the technology as an alternative to conventional experimental methods. A 2024 review abstract characterizes lactic acid as once considered a neglected metabolic waste product and says it has since become a research topic.
Why Microfluidics for Strain Screening?
Microfluidics has emerged as a powerful tool in biotechnology for several key reasons:
- Miniaturization: Microfluidic devices allow researchers to perform experiments with extremely small volumes of liquids, reducing reagent consumption and waste.
- Automation: These systems can automate many of the steps involved in bioprocess development, increasing efficiency and reducing the need for manual labor.
- High-Throughput Screening: Microfluidic platforms can be designed to run multiple experiments simultaneously, enabling the rapid screening of many different strains or conditions.
- Real-Time Monitoring: Integrated sensors can provide real-time data on key parameters like pH, dissolved oxygen, and biomass, giving researchers a more detailed understanding of cell behavior.
Transport, Devices, and Future Applications
A review of lactic acid tolerance in Saccharomyces cerevisiae reports that lactate-proton symport may no longer be thermodynamically feasible under industrially relevant conditions of low extracellular pH and high extracellular lactic acid concentration. Because Ady2 and Jen1 use this symport mechanism, the review suggests other transport mechanisms must mediate export under those harsh conditions. Nature defines microfluidics as the engineering or use of devices applying fluid flow to channels smaller than 1 millimetre in at least one dimension, and notes that such devices can reduce reagent consumption. A 2024 review discusses droplet-based lab-on-a-chip biotechnology and future directions for wider use in industrial production and biomedical analyses.
Scale-Up and Representativeness Limits
A review of yeast producers says adaptive laboratory evolution can improve strain tolerance and productivity, but is limited by random mutations, time requirements, and difficulty translating lab-scale improvements to industrial conditions. A bioprocess microfluidics review identifies barriers to industrial uptake: insufficient monitoring of process variables and automation, inadequate sample volume for quality control, and lack of downstream-processing integration. A microbioreactor review notes that organisms performing best under strictly controlled conditions may differ from those best under uncontrolled batch conditions, while screening is predominantly conducted in batch. It adds that tools combining high throughput with dynamic control over cultivation conditions are not yet available; a review of microfluidic single-cell scale-down systems also says most have a limited choice of cultivation parameters that do not represent bioprocess-relevant conditions.
Enrichment of L-Lactate Producers
A study on microfluidic high-throughput culturing reports enriching L-lactate-producing Escherichia coli clones 5,800-fold from a population containing one L-lactate producer per 10⁴ D-lactate producers. This result illustrates the study's use of single-cell culturing to select clones based on extracellular metabolite production or consumption. The supplied source reports this enrichment figure but provides no direct comparison with a non-microfluidic method.
The Future of Bioproduction
The research discussed highlights the immense potential of microfluidics to revolutionize bioprocess development. By enabling faster, more efficient, and more data-rich experiments, these technologies are paving the way for optimized production of valuable compounds.
Detection and Fermentation Contexts
A 2022 source describes a lactic acid detection window with six metal layers and a ruthenium dioxide (RuO₂) film functionalized with lactase; it reports integration of a microfluidic system with the biosensor to support more diversified detection. A 2017 source notes that lactic acid bacteria are widely used in dairy production, where they produce lactic acid and other aroma compounds that contribute to the taste and flavor of fermented milk products. These examples cover sensing and food fermentation, respectively, rather than demonstrating that one system performs both tasks.
Biobased Market Drivers
A supplied market overview describes the biobased lactic acid market as dynamic and driven by increasing demand across end-use sectors. It specifically names biodegradable plastics and food and beverage among those sectors. The snippet provides no market-size figure or dated forecast, so it does not establish a quantified outlook.
As microfluidic technology continues to advance, we can expect even more sophisticated tools for strain engineering, bioprocess control, and real-time monitoring. This will lead to more sustainable and cost-effective biomanufacturing practices.
For researchers and companies working in biotechnology, embracing microfluidics is essential to staying competitive and driving innovation in the field. The insights gained from these miniature experiments will undoubtedly shape the future of bioproduction.